BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12595753)

  • 41. Protective effects of thymoquinone against cholestatic oxidative stress and hepatic damage after biliary obstruction in rats.
    Oguz S; Kanter M; Erboga M; Erenoglu C
    J Mol Histol; 2012 Apr; 43(2):151-9. PubMed ID: 22270828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
    Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Melatonin attenuates oxidative stress, liver damage and hepatocyte apoptosis after bile-duct ligation in rats.
    Aktas C; Kanter M; Erboga M; Mete R; Oran M
    Toxicol Ind Health; 2014 Oct; 30(9):835-44. PubMed ID: 23095487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats.
    Wang G; Shen H; Rajaraman G; Roberts MS; Gong Y; Jiang P; Burczynski F
    Eur J Pharmacol; 2007 Mar; 560(1):61-8. PubMed ID: 17292345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis.
    Lee TY; Lee KC; Chang HH
    Apoptosis; 2010 Aug; 15(8):904-14. PubMed ID: 20446039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heme oxygenase-1 overexpression increases liver injury after bile duct ligation in rats.
    Froh M; Conzelmann L; Walbrun P; Netter S; Wiest R; Wheeler MD; Lehnert M; Uesugi T; Scholmerich J; Thurman RG
    World J Gastroenterol; 2007 Jul; 13(25):3478-86. PubMed ID: 17659695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents.
    Kageyama Y; Ikeda H; Watanabe N; Nagamine M; Kusumoto Y; Yashiro M; Satoh Y; Shimosawa T; Shinozaki K; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Yokota H; Koyama T; Ishimaru K; Okamoto Y; Takuwa Y; Koike K; Yatomi Y
    Hepatology; 2012 Oct; 56(4):1427-38. PubMed ID: 22505286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired ketogenesis is a major mechanism for disturbed hepatic fatty acid metabolism in rats with long-term cholestasis and after relief of biliary obstruction.
    Lang C; Berardi S; Schäfer M; Serra D; Hegardt FG; Krähenbühl L; Krähenbühl S
    J Hepatol; 2002 Nov; 37(5):564-71. PubMed ID: 12399220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy.
    Dhanda S; Sunkaria A; Halder A; Sandhir R
    Metab Brain Dis; 2018 Feb; 33(1):209-223. PubMed ID: 29138968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-fibrotic effect of Holothuria arenicola extract against bile duct ligation in rats.
    Fahmy SR
    BMC Complement Altern Med; 2015 Feb; 15():14. PubMed ID: 25652675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of resveratrol against oxidative stress in cholestasis.
    Ara C; Kirimlioglu H; Karabulut AB; Coban S; Ay S; Harputluoglu M; Kirimlioglu V; Yilmaz S
    J Surg Res; 2005 Aug; 127(2):112-7. PubMed ID: 16083749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress.
    Zhao SS; Li NR; Zhao WL; Liu H; Ge MX; Zhang YX; Zhao LY; You XF; He HW; Shao RG
    Acta Pharmacol Sin; 2018 Feb; 39(2):213-221. PubMed ID: 28748913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Copper deficiency exacerbates bile duct ligation-induced liver injury and fibrosis in rats.
    Song M; Zhou Z; Chen T; Zhang J; McClain CJ
    J Pharmacol Exp Ther; 2011 Oct; 339(1):298-306. PubMed ID: 21784888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gallic acid improves liver cirrhosis by reducing oxidative stress and fibrogenesis in the liver of rats induced by bile duct ligation.
    Jafaripour L; Sohrabi Zadeh B; Jafaripour E; Ahmadvand H; Asadi-Shekaari M
    Scand J Gastroenterol; 2023; 58(12):1474-1483. PubMed ID: 37452479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome.
    Luo B; Tang L; Wang Z; Zhang J; Ling Y; Feng W; Sun JZ; Stockard CR; Frost AR; Chen YF; Grizzle WE; Fallon MB
    Gastroenterology; 2005 Aug; 129(2):682-95. PubMed ID: 16083721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc.
    Sharawy MH; Abdel-Rahman N; Megahed N; El-Awady MS
    Life Sci; 2018 Oct; 211():245-251. PubMed ID: 30243650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time course of collagen peak in bile duct-ligated rats.
    Tarcin O; Basaranoglu M; Tahan V; Tahan G; Sücüllü I; Yilmaz N; Sood G; Snyder N; Hilman G; Celikel C; Tözün N
    BMC Gastroenterol; 2011 Apr; 11():45. PubMed ID: 21527001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism.
    Peterson TC; Neumeister M
    Immunopharmacology; 1996 Mar; 31(2-3):183-93. PubMed ID: 8861744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Grape seed extract reduces oxidative stress and fibrosis in experimental biliary obstruction.
    Dulundu E; Ozel Y; Topaloglu U; Toklu H; Ercan F; Gedik N; Sener G
    J Gastroenterol Hepatol; 2007 Jun; 22(6):885-92. PubMed ID: 17565645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.